Analysis: John Boozman's buy of ALB (Albemarle Corporation)
Assessment: On watch
A borderline WATCHLIST/IGNORE trade where a committee member initiated a small, likely adviser-managed position in ALB shortly after strong public earnings, but on the exact day the company's CEO was selling heavily.
- Member: John Boozman
- Party / state: Republican
- Chamber: Senate
- Transaction: Buy
- Amount: $1,001 - $15,000
- Ticker: ALB
- Company: Albemarle Corporation
- Trade date: 2026-05-15
- Disclosure date: 2026-06-16
- Disclosure lag: 32 days
Executive summary
This research record covers Sen. John Boozman’s disclosed purchase of Albemarle (ALB) on 2026-05-15 ($1,001-$15,000), filed on 2026-06-16 (32-day lag), and the same-day purchase of PLTR. Using the provided SEC EDGAR enrichment, relevant issuer events in the months around the trade include multiple Albemarle 8-K filings (including a 2026-05-06 earnings-related 8-K) and Form 4 insider sales by the Chairman & CEO dated the same day as the senator’s trade. Other primary-source checks (Congress.gov, Federal Register, USAspending, Regulations.gov, news) could not be executed due to lack of web access in this environment.
Within the user-provided trading-history dataset, ALB appears only once (a first-time purchase on 2026-05-15) at the $1,001-$15,000 range, which is the most common size range observed across the member’s broader activity. The same-day PLTR purchase indicates that ALB was part of a small batch of purchases executed on the same date rather than an isolated single-ticker action, based on the provided “same-day portfolio activity” section. From the provided SEC EDGAR enrichment, Albemarle filed several 8-Ks in the quarter leading into and after the trade date, including an earnings-related 8-K filed 2026-05-06 (Item 2.02). In the provided Form 4 window (2026-04-15 to 2026-06-14), the only listed insider activity was three CEO sales dated 2026-05-15 (filed 2026-05-19). Due to inability to access Congress.gov/Federal Register/USAspending/Regulations.gov/news and inability to retrieve the 10-K, this record cannot include documented legislative/regulatory/contract catalysts or 10-K risk-factor excerpts for Albemarle in the specified timing windows.
Timeline
- 2026-03-04 — Albemarle filed Form 8-K (Items: 5.02, 7.01, 9.01) with exhibit press release (board appointments).
- 2026-03-06 — Albemarle filed Form 8-K (Items: 2.01, 7.01, 8.01, 9.01).
- 2026-03-25 — Albemarle filed Form 8-K (Item: 1.01, 9.01).
- 2026-04-17 — Albemarle filed Form 8-K (Item: 5.02).
- 2026-05-06 — Albemarle filed Form 8-K (Items: 2.02, 9.01) including earnings release exhibit (Exhibit 99.1).
- 2026-05-08 — Albemarle filed Form 8-K (Items: 5.02, 5.07, 9.01).
- 2026-05-15 — Sen. John Boozman purchased ALB ($1,001-$15,000). Same-day: purchased PLTR ($1,001-$15,000).
- 2026-05-15 — Albemarle CEO (Kent Masters) reported three sales on 2026-05-15 at prices ~$183-$184 per share (Form 4 filed 2026-05-19).
- 2026-06-05 — Albemarle filed Form 8-K (Item: 5.02).
- 2026-06-16 — Trade disclosure filed for 2026-05-15 ALB purchase.
Independent analysis of public financial disclosures. Not financial or investment advice.